Bruno Tasso

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Structure Activity Relationship

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

International journal of molecular sciences

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Maria Schito, Debora Caviglia, Susanna Penco, Andrea Spallarossa, Elena Cichero, Bruno Tasso, Chiara Brullo
New Pyrazolyl Thioureas Active against the Staphylococcus Genus. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Anna Maria Schito, Debora Caviglia, Susanna Penco, Andrea Spallarossa, Elena Cichero, Bruno Tasso, Chiara Brullo
New Pyrazolyl Thioureas Active against the Staphylococcus Genus. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Federica Rapetti, Andrea Spallarossa, Eleonora Russo, Debora Caviglia, Carla Villa, Bruno Tasso, Maria Grazia Signorello, Camillo Rosano, Erika Iervasi, Marco Ponassi, Chiara Brullo
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives. Molecules (Basel, Switzerland) 29 (10) (2024)
Anna Maria Schito, Debora Caviglia, Susanna Penco, Andrea Spallarossa, Elena Cichero, Bruno Tasso, Chiara Brullo
New Pyrazolyl Thioureas Active against the Staphylococcus Genus. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Federica Rapetti, Andrea Spallarossa, Eleonora Russo, Debora Caviglia, Carla Villa, Bruno Tasso, Maria Grazia Signorello, Camillo Rosano, Erika Iervasi, Marco Ponassi, Chiara Brullo
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives. Molecules (Basel, Switzerland) 29 (10) (2024)
Michele Fiore, Michele Mosconi, Francesco Bonì, Alice Parodi, Annalisa Salis, Bruno Tasso, Eloise Mastrangelo, Enrico Millo, Federica Cossu
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells. Molecules (Basel, Switzerland) 28 (1) (2023)
Giulia Elda Valenti, Antonella Roveri, Rina Venerando, Paola Menichini, Paola Menichini, Bruno Tasso, Nicola Traverso, Cinzia Domenicotti, Barbara Marengo
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis. Antioxidants (Basel, Switzerland) 13 (1) (2023)
Michele Fiore, Michele Mosconi, Francesco Bonì, Alice Parodi, Annalisa Salis, Bruno Tasso, Eloise Mastrangelo, Enrico Millo, Federica Cossu
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells. Molecules (Basel, Switzerland) 28 (1) (2023)
Giulia Elda Valenti, Antonella Roveri, Rina Venerando, Paola Menichini, Paola Menichini, Bruno Tasso, Nicola Traverso, Cinzia Domenicotti, Barbara Marengo
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis. Antioxidants (Basel, Switzerland) 13 (1) (2023)
Eleonora Russo, Carola Grondona, Chiara Brullo, Andrea Spallarossa, Carla Villa, Bruno Tasso
Indole Antitumor Agents in Nanotechnology Formulations: An Overview. Pharmaceutics 15 (7) (2023)
Bruno Tasso, Laura Beatrice Mattioli, Michele Tonelli, Vito Boido, Alberto Chiarini, Fabio Sparatore, Roberta Budriesi
Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3. Molecules (Basel, Switzerland) 28 (19) (2023)
Michele Fiore, Michele Mosconi, Francesco Bonì, Alice Parodi, Annalisa Salis, Bruno Tasso, Eloise Mastrangelo, Enrico Millo, Federica Cossu
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells. Molecules (Basel, Switzerland) 28 (1) (2023)
Chiara Brullo, Debora Caviglia, Andrea Spallarossa, Silvana Alfei, Scott G Franzblau, Bruno Tasso, Anna Maria Schito
Microbiological Screening of 5-Functionalized Pyrazoles for the Future Development of Optimized Pyrazole-Based Delivery Systems. Pharmaceutics 14 (9) (2022)
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, Carla Villa, Chiara Brullo
The Development of FAK Inhibitors: A Five-Year Update. International journal of molecular sciences 23 (12) (2022)
Eleonora Russo, Andrea Spallarossa, Bruno Tasso, Carla Villa, Chiara Brullo
Nanotechnology for Pediatric Retinoblastoma Therapy. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Alice Parodi, Giada Righetti, Emanuela Pesce, Annalisa Salis, Valeria Tomati, Cristina Pastorino, Bruno Tasso, Mirko Benvenuti, Gianluca Damonte, Nicoletta Pedemonte, Elena Cichero, Enrico Millo
Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Bruno Tasso, Andrea Spallarossa, Eleonora Russo, Chiara Brullo
The Development of BTK Inhibitors: A Five-Year Update. Molecules (Basel, Switzerland) 26 (23) (2021)
Eleonora Russo, Andrea Spallarossa, Bruno Tasso, Carla Villa, Chiara Brullo
Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective. International journal of molecular sciences 22 (12) (2021)
Marta Campora, Valeria Francesconi, Silvia Schenone, Bruno Tasso, Michele Tonelli
Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 14 (1) (2021)
Chiara Brullo, Carla Villa, Bruno Tasso, Eleonora Russo, Andrea Spallarossa
Btk Inhibitors: A Medicinal Chemistry and Drug Delivery Perspective. International journal of molecular sciences 22 (14) (2021)
Giada Righetti, Monica Casale, Nara Liessi, Bruno Tasso, Annalisa Salis, Michele Tonelli, Enrico Millo, Nicoletta Pedemonte, Paola Fossa, Elena Cichero
Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors. International journal of molecular sciences 21 (21) (2020)
Michele Tonelli, Anna Sparatore, Nicoletta Basilico, Loredana Cavicchini, Silvia Parapini, Bruno Tasso, Erik Laurini, Sabrina Pricl, Vito Boido, Fabio Sparatore
Quinolizidine-Derived Lucanthone and Amitriptyline Analogues Endowed with Potent Antileishmanial Activity. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)